| Cell line name |
OV-MZ-30 |
| Synonyms |
OVarian-MainZ-30 |
| Accession |
CVCL_X971 |
| Resource Identification Initiative |
To cite this cell line use: OV-MZ-30 (RRID:CVCL_X971) |
| Comments |
Omics: Transcriptomics; Microarray. Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. |
| Disease |
Ovarian serous cystadenocarcinoma (NCIt: C7978) |
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
| Sex of cell |
Female |
| Age at sampling |
56Y |
| Category |
Cancer cell line |
| Publications | PubMed=11242531; DOI=10.1089/10430340150504019 Ansgar Bruning, Tanja Kohler, Sven Roy Quist, Shan Wang-Gohrke, Volker Jochen Mobus, Rolf Kreienberg, Ingo Bernard Runnebaum; Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphaVbeta3. Hum. Gene Ther. 12:391-399(2001) PubMed=11925137; DOI=10.1006/gyno.2002.6597 Matthias Oppitz, Volker Jochen Mobus, S. Brock, Ulrich Drews; Muscarinic receptors in cell lines from ovarian carcinoma: negative correlation with survival of patients. Gynecol. Oncol. 85:159-164(2002) DOI=10.5282/edoc.3898 Nicole Isabel Euer; Identification of target genes for the therapy and diagnosis of ovarian carcinoma. Thesis PhD (2005); Ludwig Maximilians University of Munich; Munich; Germany PubMed=15706405; DOI=10.3892/or.13.3.375 Nicole Isabel Euer, Sepp Kaul, Helmut Deissler, Volker Jochen Mobus, Robert Zeillinger, Ulrich H. Weidle; Identification of L1CAM, Jagged2 and neuromedin U as ovarian cancer-associated antigens. Oncol. Rep. 13:375-387(2005) |
| Cross-references |
| Encyclopedic resources |
Wikidata; Q54936852
|
| Entry history |
| Entry creation | 05-Sep-2014 |
| Last entry update | 27-Nov-2025 |
| Version number | 8 |
|---|